| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/21/2002 | US20020035078 Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity |
| 03/21/2002 | US20020035061 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 03/21/2002 | US20020035056 54420, a novel human calcium channel |
| 03/21/2002 | US20020034822 Integrative protein-DNA cochleate formulations and methods for transforming cells |
| 03/21/2002 | US20020034821 Methods and compositions for enhancing the delivery of a nucleic acid to a cell |
| 03/21/2002 | US20020034820 Sebocytes, sebocyte-cell line and uses thereof |
| 03/21/2002 | US20020034816 Genetically engineered gram-positive bacterium for the generation of ethyl alcohol |
| 03/21/2002 | US20020034814 Nuclelotide sequences; for use as diagnostic tools in genetic engineering |
| 03/21/2002 | US20020034813 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging |
| 03/21/2002 | US20020034812 Caspase homologue |
| 03/21/2002 | US20020034807 Nucleotide sequences coding enzymatic proteins; for use in the treatment of cell proliferation and differention disorders; antiproliferative agents |
| 03/21/2002 | US20020034806 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 03/21/2002 | US20020034805 Nucleotide sequences coding enzymatic polypepties for use in development of anticarcinogenic agents |
| 03/21/2002 | US20020034804 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agent |
| 03/21/2002 | US20020034803 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/21/2002 | US20020034802 Crystals of the alpha 1 beta 1 integrin I-domain and their use |
| 03/21/2002 | US20020034801 Nucleotide sequences coding redox proteins for use in treatment of cell proliferative, diffentiation and cardiovascular disorders |
| 03/21/2002 | US20020034800 Preferential bone marrow polypeptides; for generation of erythrocytes; for healing fractured bones |
| 03/21/2002 | US20020034799 Nucleotide sequences coding transport polypeptide; for use in gene therapy |
| 03/21/2002 | US20020034798 High-activity phytase compositions |
| 03/21/2002 | US20020034797 Modified modular pks with retained scaffold |
| 03/21/2002 | US20020034792 Reduced ability to incorporate dideoxynucleotides |
| 03/21/2002 | US20020034790 Calibration of nucleotide sequences; generate preferential nucleotide sequences, incubate with hapten, remove and evaluate hybridized nucleotide sequences |
| 03/21/2002 | US20020034788 Improving dicarboxylic acid production in yeast by replacing the native promoter of a target gene with a heterologous promoter from a yeast gene having a desired level of activity |
| 03/21/2002 | US20020034787 Nucleotide sequences coding polypeptides for use in treatment of wounds, burns, ulcers, nervous system disorders and tumors |
| 03/21/2002 | US20020034786 Nucleotide sequences coding G protein coupled receptor; for use in the diagnosis and treatment of defects in signal transduction |
| 03/21/2002 | US20020034784 Novel molecules of the card-related protein family and uses thereof |
| 03/21/2002 | US20020034783 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis and treatment of tumors; antitumor agents |
| 03/21/2002 | US20020034781 Nucleotide sequences coding membrane protein for use in treatment and diagnosis of pain defects |
| 03/21/2002 | US20020034780 Novel human protein kinases and uses therefor |
| 03/21/2002 | US20020034779 Novel argS |
| 03/21/2002 | US20020034778 Peptide; for use in drug screening; for use as a diagnostic tool; for use in the treatment of nervous system disorders |
| 03/21/2002 | US20020034777 Modulator of use in the diagnosis, prevention and treatment of inflammation, cancer and nervous system disorders; hypotensive agent |
| 03/21/2002 | US20020034776 Genetically engineering enzymatic proteins; transform eschericha, generate mutations, transmit mutation to another microoganism and detect enzymatic activity, recover microorganism with adjusted enzymatic activity |
| 03/21/2002 | US20020034771 Screening for preferential immunoglobulin; obtain human immunoglobulin receptor segment, incubate with antigen, detect complex formation |
| 03/21/2002 | US20020034770 Modulators of cyclin dependent kinases; for use in the treatment of cancer; antitumor agents |
| 03/21/2002 | US20020034767 Screening for modulators of enzymatic activity; incubate sample with modulators, detect adjustment in enzymatic activity, adjustment in enzymatic activity indicates modulator |
| 03/21/2002 | US20020034765 Method for reducing the immunogenicity of antibody variable domains |
| 03/21/2002 | US20020034764 Diarylsulfonylurea binding proteins |
| 03/21/2002 | US20020034762 Monitorng preferential particles in sample; provide opaque glass support, incubate with sample, illuminate surface with light, monitor fluorescent emission, emission indicates presence of preferential particle in sample |
| 03/21/2002 | US20020034761 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 03/21/2002 | US20020034759 Metallic solid supports modified with nucleic acids |
| 03/21/2002 | US20020034758 Novel human genes and gene expressions products: II |
| 03/21/2002 | US20020034756 Method of detection by enhancement of silver staining |
| 03/21/2002 | US20020034755 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/21/2002 | US20020034754 Fluorescent quenching detection reagents and methods |
| 03/21/2002 | US20020034753 Novel assay for nucleic acid analysis |
| 03/21/2002 | US20020034747 Using encoded bead conjugate comprising microsphere semiconductor nanocrystal having fluorescence characteristics and polynucleotide having proximal end and distal end wherein polynucleotide is linked to microsphere at proximal end |
| 03/21/2002 | US20020034743 Nucleotide sequences coding protein for use in the detection, diagnosis, prevention and treatment of human cancers |
| 03/21/2002 | US20020034742 Disease association by stratification |
| 03/21/2002 | US20020034738 Human vascular ibp-like growth factor |
| 03/21/2002 | US20020034736 Nucleotide sequences coding modulators for use in therapy against tumors, retinopathy, perfusion injuries, fibrosis, artherosclerosis, angiogenesis, inflammation, and restenosis; antiischemic and antitumor agents |
| 03/21/2002 | US20020034734 Vaccine composition for preventing or treating hepatitis C |
| 03/21/2002 | US20020034733 Novel methods for displaying (poly) pepti des/proteins on bacteriophage particles via disulfide bonds |
| 03/21/2002 | US20020034732 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 03/21/2002 | US20020034730 For identifying compounds that bind to ion channel and may have antiarrhythmic activity |
| 03/21/2002 | US20020034728 Screening compounds that modulate calcium release activated channel activity by contacting compound and calcium channel activator with calcium channel expressing cells containing reporter construct, measuring reporter gene expression |
| 03/21/2002 | US20020034551 Method of making microencapsulated DNA for vaccination and gene therapy |
| 03/21/2002 | US20020034519 Modified bovine adenovirus having altered tropism |
| 03/21/2002 | US20020034516 Test kits; genetic engineering |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034512 Method of making a vaccine |
| 03/21/2002 | US20020034510 Genetic engineered protein; antiischemic agents |
| 03/21/2002 | US20020034506 Method for treatment of tumors using nucleic acid ligands to PDGF |
| 03/21/2002 | US20020034502 Retroviral vectors |
| 03/21/2002 | US20020034498 Polymer-modified viruses |
| 03/21/2002 | US20020034393 Vector |
| 03/21/2002 | DE10132947A1 Für das rodA-Gen kodierte Nukleotidsequenzen For the rodA gene encoded nucleotide sequences |
| 03/21/2002 | DE10132176A1 Neue für das fts-Gen kodierende Nukleotidsequenzen New coding for the fts gene nucleotide sequences |
| 03/21/2002 | DE10112430A1 Neue für das dep33-Gen kodierende Nukleotidsequenzen New coding for the dep33 gene nucleotide sequences |
| 03/21/2002 | DE10044648A1 Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material Method of replication or removal of Cirocoviren from biological material |
| 03/21/2002 | DE10044373A1 Neues Reagenz zur Markierung von Nukleinsäuren A new reagent for the labeling of nucleic acids |
| 03/21/2002 | DE10043674A1 New antisense oligonucleotides and ribozymes, useful for treating e.g. pain and for diagnosis, are directed against mRNA for vanilloid-family receptors |
| 03/21/2002 | CA2703141A1 Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in situ analysis |
| 03/21/2002 | CA2585083A1 Directed evolution method |
| 03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | CA2422814A1 Cripto mutant and uses thereof |
| 03/21/2002 | CA2422603A1 Vectors for molecule delivery to cd11b expressing cells |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422497A1 Transporters and ion channels |
| 03/21/2002 | CA2422454A1 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | CA2422366A1 Targeted genetic manipulation using mu bacteriophage cleaved donor complex |
| 03/21/2002 | CA2422362A1 Modulation of meiotic recombination |
| 03/21/2002 | CA2422314A1 Microarrayed organization of transcription factor target genes |
| 03/21/2002 | CA2422310A1 Detection of microsatellite instability and its use in diagnosis of tumors |
| 03/21/2002 | CA2422293A1 Plant genes, the expression of which are altered by pathogen infection |
| 03/21/2002 | CA2422288A1 Novel mammalian receptor genes and uses |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2422237A1 Genes and the physics of the dna double-helix. formulation of a physics-based gene identification (pbgi) method: ab initio identification of genes in eukaryotic genomes |
| 03/21/2002 | CA2422229A1 Calcium binding proteins |
| 03/21/2002 | CA2422190A1 Compositions and methods for stable transformation using mu bacteriophage cleaved donor complex |
| 03/21/2002 | CA2422175A1 Modulation of homologous recombination with single stranded dna binding proteins |
| 03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | CA2422152A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | CA2422080A1 Method to identify therapeutic antibody targets associated with a therapeutic response |
| 03/21/2002 | CA2422068A1 Method for treatment of insulin resistance in obesity and diabetes |
| 03/21/2002 | CA2422053A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | CA2422041A1 Antimicrobial peptides and methods of use |
| 03/21/2002 | CA2421963A1 Directed evolution method |